首页> 外文期刊>European journal of ophthalmology >Retinal pigment epithelial marginal retraction after photodynamic therapy for choroidal neovascularization in pathologic myopia.
【24h】

Retinal pigment epithelial marginal retraction after photodynamic therapy for choroidal neovascularization in pathologic myopia.

机译:病理性近视的光动力疗法治疗脉络膜新生血管后视网膜色素上皮边缘收缩。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To report the incidence of retinal pigment epithelial (RPE) marginal retraction after verteporfin photodynamic therapy (PDT) for subfoveal choroidal neovascularization (CNV) in pathologic myopia (PM). METHODS: Retrospective review of 236 patients treated with PDT for subfoveal CNV due to PM. RESULTS: RPE marginal retraction was found in 3 eyes (1.3%), and a decrease of a mean of five lines of vision was reported to occur 10-15 days after treatment. At the end of followup two eyes lost three lines and one six lines from baseline. CONCLUSIONS: RPE marginal retraction as an early complication of PDT for subfoveal CNV secondary to PM is rare. The low incidence of this adverse event, however, should not preclude recommendations for PDT in myopic eyes that could benefit from this treatment modality.
机译:目的:报道病理性近视眼中视网膜下中央脉络膜新生血管形成(CNV)的韦替泊芬光动力疗法(PDT)后视网膜色素上皮(RPE)边缘回缩的发生率。方法:回顾性研究了236例因PM接受PDT治疗的小凹下CNV患者。结果:3眼(1.3%)发现RPE边缘收缩,据报道在治疗后10-15天平均减少了5个视线。随访结束时,两只眼睛从基线损失了三行和六行。结论:RPE边缘回缩作为PDT继发于PM的小凹下CNV的早期并发症是罕见的。但是,这种不良事件的发生率较低,不应排除可以从这种治疗方式中受益的近视眼PDT的建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号